Table 2 Type of anticoagulant therapy given for children younger than 2Â years diagnosed with VTE
|  | Total population, N = 346 | Children aged < 0.5 year, N = 271 | Children aged 0.5-2 years, N = 75 |
|---|---|---|---|
CVC-VTE, n (%) | 227 (65.6) | 175 (64.6) | 52 (69.3) |
 Anticoagulation,a n (%) | 199 (88) | 153 (87) | 46 (88) |
 No anticoagulation, n (%) | 28 (12) | 22 (13) | 6 (12) |
Non-CVC-VTE, n (%) | 119 (34.4) | 96 (35.4) | 23 (30.7) |
 Anticoagulation,a n (%) | 110 (92) | 88 (92) | 22 (96) |
 No anticoagulation, n (%) | 9 (8) | 8 (8) | 1 (4) |
CVC-VTE | |||
 Extremity/caval vein thrombosis/pulmonary embolism | 89 | 34 | |
  Anticoagulation,a n (%) | 76 (85) | 30 (88) | |
  No anticoagulation, n (%) | 13 (15) | 4 (12) | |
 Cardiac thrombosis | 20 | 4 | |
  Anticoagulation,a n (%) | 18 (90) | 4 (100) | |
  No anticoagulation, n (%) | 2 (10) | 0 | |
 Renal vein thrombosis | 1 | 0 | |
  Anticoagulation,a n (%) | 1 (100) | – | |
  No anticoagulation, n (%) | 0 | – | |
 Portal vein thrombosis | 18 | 0 | |
  Anticoagulation,a n (%) | 14 (78) | – | |
  No anticoagulation, n (%) | 4 (22) | – | |
 Jugular/subclavian vein thrombosis | 47 | 14 | |
  Anticoagulation,a n (%) | 44 (94) | 12 (86) | |
  No anticoagulation, n (%) | 3 (6) | 2 (14) | |
Non-CVC-VTE | |||
 Cerebral venous sinus thrombosis | 37 | 8 | |
  Anticoagulation,a n (%) | 34 (92) | 8 (100) | |
  No anticoagulation, n (%) | 3 (8) | 0 | |
 Extremity/caval vein thrombosis/pulmonary embolism | 16 | 11 | |
  Anticoagulation,a n (%) | 14 (88) | 11 (100) | |
  No anticoagulation, n (%) | 2 (13) | 0 | |
 Cardiac thrombosis | 12 | 0 | |
  Anticoagulation,a n (%) | 12 (100) | – | |
  No anticoagulation, n (%) | 0 | – | |
 Renal vein thrombosisb | 14 | 0 | |
  Anticoagulation,a n (%) | 12 (86) | – | |
  No anticoagulation, n (%) | 2 (14) | – | |
 Portal vein thrombosisb | 14 | 1 | |
  Anticoagulation,a n (%) | 14 (100) | 0 | |
  No anticoagulation, n (%) | 0 | 1 (100) | |
 Jugular/subclavian vein thrombosis | 4 | 3 | |
  Anticoagulation,a n (%) | 3 (75) | 3 (100) | |
  No anticoagulation, n (%) | 1 (25) | 0 | |